Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -0.90% vs 2.77% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 11.39% vs 16.18% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -15.00% vs 36.00% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 33.33% vs -57.14% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 19.74% vs 15.93% in Mar 2024
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
7.87
0.84
10.67%
Share Warrants & Outstandings
Total Reserve
1.65
9.63
-7.98
-82.87%
Shareholder's Funds
10.35
17.49
-7.14
-40.82%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
5.38
6.87
-1.49
-21.69%
Secured Loans
1.02
2.50
-1.48
-59.20%
Unsecured Loans
4.37
4.37
0.00
0.00%
Deferred Tax Assets / Liabilities
0.09
0.80
-0.71
-88.75%
Other Long Term Liabilities
0.88
0.00
0.88
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.54
-0.54
-100.00%
Total Non-Current Liabilities
4.16
8.21
-4.05
-49.33%
Current Liabilities
Trade Payables
2.06
16.85
-14.79
-87.77%
Other Current Liabilities
1.87
5.64
-3.77
-66.84%
Short Term Borrowings
7.84
26.40
-18.56
-70.30%
Short Term Provisions
0.00
1.86
-1.86
-100.00%
Total Current Liabilities
11.77
50.75
-38.98
-76.81%
Total Liabilities
26.28
76.46
-50.18
-65.63%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.71
17.58
-13.87
-78.90%
Less: Accumulated Depreciation
0.82
9.65
-8.83
-91.50%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.89
7.93
-5.04
-63.56%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.88
-0.88
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.04
0.02
0.02
100.00%
Long Term Loans & Advances
0.00
0.07
-0.07
-100.00%
Other Non Current Assets
0.00
0.28
-0.28
-100.00%
Total Non-Current Assets
2.93
9.18
-6.25
-68.08%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.78
36.15
-29.37
-81.24%
Sundry Debtors
10.69
13.00
-2.31
-17.77%
Cash and Bank
1.24
4.62
-3.38
-73.16%
Other Current Assets
0.52
2.73
-2.21
-80.95%
Short Term Loans and Advances
4.12
10.79
-6.67
-61.82%
Total Current Assets
23.35
67.28
-43.93
-65.29%
Net Current Assets (Including Current Investments)
11.58
16.53
-4.95
-29.95%
Total Current Assets Excluding Current Investments
23.35
67.28
-43.93
-65.29%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
26.28
76.46
-50.18
-65.63%
Contingent Liabilities
0.00
7.41
-7.41
-100.00%
Total Debt
8.84
33.27
-24.43
-73.43%
Book Value per share (adjusted)
12.39
22.24
-9.85
-44.29%
Annual - Borrowings
Borrowings 11.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.90% vs 2.77% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.39% vs 16.18% in Mar 2024
Annual - Fixed Assets
Fixed Assets 2.89 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.00% vs 36.00% in Mar 2024
Annual - Investments
Investments 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 33.33% vs -57.14% in Mar 2024
Annual - Current Assets
Current Assets 23.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.74% vs 15.93% in Mar 2024






